Article

Are Pre-frail and Frail Amyloid Positive Individuals Eligible to Lecanemab? A cross-sectional analysis from the Cogfrail Real-World Cohort

2025-10-17

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Following the positive outcomes of the Clarity-AD trial, Lecanemab received marketing authorization from the European Medicines Agency (EMA) and is expected to become available across Europe. However, the trial did not specifically evaluate frailty, making it difficult to estimate the potential effects of Lecanemab among frail individuals. This study aimed to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c2b2a694-e351-53f6-a0f7-b66afd3dfc84
DOI: 10.21203/rs.3.rs-7713653/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Are Pre-frail and Frail Amyloid Positive Individuals Eligible to Lecanemab? A cross-sectional analysis from the Cogfrail Real-World CohortDOI 10.21203/rs.3.rs-7713653/v1Read

Design and Rationale of the FICAPP Study: Frailty in Cardiac Amyloidosis: Profiling the Phenotype.Semantic proximity Read

Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer’s disease to individuals with MCI or early AD in the general populationSemantic proximity Read

New horizons in the diagnosis and management of Alzheimer's Disease in older adults.Semantic proximity Read

Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac AmyloidosisSemantic proximity Read

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.Semantic proximity Read

Domains of Frailty as Early Risk Factors for Alzheimer’s Disease – Genetic and Causal EvidenceSemantic proximity Read

Real-world experience with lecanemab therapy for Alzheimer’s disease in the Intermountain WestSemantic proximity Read

Patient attitude towards lecanemab: results from a survey within the European Alzheimer’s disease consortium (EADC), the German memory clinic network (DNG) and Austrian memory centersSemantic proximity Read

Risk factors and a nomogram for predicting cognitive frailty in Chinese patients with lung cancer receiving drug therapy: a single-center cross-sectional studySemantic proximity Read

Distinct Frailty Phenotypes Are Associated with Cognitive Performance and Brain Structure in Alzheimer’s DiseaseSemantic proximity Read

Blood-based biomarkers of frailty in solid tumors: a systematic review.Semantic proximity Read

A pragmatic three-component clinical score for cognitive risk stratification in older adults with multimorbidity and frailty.Semantic proximity Read